stock-market-forex-trading-graph-graphic-concept.jpg

Investor
Relations 

 

Board of Directors

Picture.jpg

Mr. Manish Gupta

Managing Director

Mr. Manish Gupta has a well-established track record of successfully leading and managing businesses across the globe. His last stint was with SeQuent Scientific Limited (SeQuent) as the CEO and Managing Director for 8 years. Previously, he has been the CEO – Pharma Business for Strides Pharma Science.

Mr. Gupta led SeQuent since 2014 and played a major role in transforming the Company from a small India-focused business to a global organization with operations in India, Turkey, Brazil and EU, emerging as India’s largest and ‘top 20’ global animal health company. He undertook a series of structural moves including inorganic initiatives with emphasis on consolidating market presence, entering new markets, and strengthening customer-centricity.
Prior to that, he was associated with Wockhardt in various capacities with his last role being as the Managing Director of Pinewood Healthcare, Ireland and CEO of Radiant Research, a CRO in USA.

Mr. Harsha Raghavan.jpg

Mr. Harsha Raghavan

Non-Executive Chairman

Mr. Harsha Raghavan, based in Mumbai, is the Managing Partner of Convergent Finance LLP. Mr. Raghavan was previously the founding MD & CEO of Fairbridge Capital Private Limited (a Fairfax Company) from its inception in 2011 where he led all investment advisory activities in India. During his time, he sourced and advised on over $2.1 billion worth of investment activity. Previously, he served as Head of India for Candover Investments, Co-Head of India for Goldman Sachs Principal Investment Area, and Vice President of Indocean Chase Capital. In these roles, Mr. Raghavan had advised on more than two dozen transactions totaling over $1.5 billion in value. Mr. Raghavan holds a Master of Business Administration degree and Master of Science degree in industrial engineering both from Stanford University and a Bachelor of Arts degree from the University of California at Berkeley, where he double-majored in computer science and economics.

Mr. Debasis Nandy.png

Mr. Debasis B Nandy

Independent Director

More than thirty years of experience in Manufacturing and Service industry, having worked across domains such as Mergers & Acquisitions, Investor Relations, Accounts & Controlling, Tax, Treasury, Budgeting, Planning and Business Finance

Led Thomas Cook through acquisition by Fairfax in 2012 and the consequent management change. As Vice President-Finance in Piramal Healthcare, he  planned & executed activities aimed at enhancing financial strength of the organization

He completed Chartered Accountancy in 1987 and subsequently attended Executive Development Program at Wharton Business School, Philadelphia in May, 2005 and London Business School, in December, 2005

Ms Radhika M Dudhat.png

Ms Radhika M Dudhat

Independent Director

She has worked on areas including transaction structuring, strategy formulation, documentation and negotiations for complex and sensitive transactions across matters pertaining to real estate, infrastructure, insolvency and bankruptcy

In legal risk management, she advises on transactional, corporate governance, and regulatory compliances. She also works on matters relating to new business structuring and applicable regulatory and contractual framework

Radhika has been appointed as the Chairperson of Corporate Law and Governance Sub-Committee of  IMC Chamber of Commerce & Industry

She is a Graduate from University of Bombay Faculty of Life Sciences, a law graduate from the University of Bombay and a Postgraduate from the University of Cambridge and Harvard University

Ms Pallavi Dinodia Gupta.png

Ms Pallavi Dinodia Gupta

Independent Director

As a Chartered Accountant, she has worked with multinationals, large Indian families and non-profit organizations while advising on valuation, corporate and tax laws. She is also trained as a lawyer and has worked with numerous businesses over the past two decades

Additionally, she has served on board of listed companies and international organizations. This includes serving as the Chairperson of APAC Region and as a key member of the global governing council for MGI Worldwide – one of the largest global networks of accounting, audit and taxation firms

Mr Prithipal Singh Kochhar.png

Mr Prithipal Singh Kochhar

Non-Executive Director

Prithi is the Founder and CEO of Naari CEO which is a company focussed on Women Health. The Company has two development and manufacturing sites in India - for intermediates, APIs and FDFs and offices in Singapore, Ukraine, US and Netherlands. He has successfully expanded operations of the Company in India, South East Asia, Europe, CIS and Africa

Earlier, he founded and served as the CEO of the Indo Phyto Chemicals Pvt Limited for eight years. Starting in 2009 with annual revenue of less than $ 250,000 he was successful in exponentially growing the business before selling majority stake in 2016.

Key Officials

Mr. Manish Gupta
Managing Director

Mr. Debasis B Nandy
Independent Director

Ms Pallavi Dinodia Gupta
Independent Director

Mr. Prithipal Singh Kochhar
Non-Executive Director

Mr. Harsha Raghavan
Non-Executive Director

Ms Radhika M Dudhat
Independent Director

Mr. S V Subha Rao
Chief Financial Officer (CFO)

CS Nandita Singh
Company Secretary and Compliance Officer

Committees

Audit Committee

Mr. Debasis B Nandy

Ms Pallavi Dinodia Gupta

Mr. Harsha Raghavan

Stakeholder Relationship Committee 

Mr. Debasis B Nandy

Ms Pallavi Dinodia Gupta

Mr. Manish Gupta

Nomination and Remuneration Committee 

Ms Radhika M Dudhat

Mr. Debasis B Nandy

Mr. Prithipal Singh Kochhar

Corporate Social Responsibility

Ms Radhika M Dudhat

Ms Pallavi Dinodia Gupta

Mr. Manish Gupta

Risk Management Committee

Mr. Harsha Raghavan

Mr. Debasis B Nandy

Ms Radhika M Dudhat

Addresses

Investors Grievance Cell

CS Nandita Singh

Company Secretary & Compliance Officer 

Jagsonpal Pharmaceuticals Limited 

T - 210 J, Shahpur Jat 

New Delhi - 110 049, 

Phone: 011-46181100 & 011-46109900 

E-mail: cs@jagsonpal.com

DETAIL OF NODAL OFFICER UNDER IEPF RULES, 2016

Registered Address

Jagsonpal Pharmaceuticals Ltd

Headquarters

T 210 J, Shahpur Jat 

New Delhi-110049
Phone: 011-46181100 & 011-46109900

MCS Share Transfer Agent Limited

F-65, Ist Floor, 
Okhla Industrial Area,Phase-I

NEW DELHI-110020

Phone: 011-41406149

Email: admin@mcsregistrars.com

Website: www.mcsregistrars.com